INTRODUCTION
Ayurveda -age old Indian art of health and medicine, and cancer -a disease about which the medical science has developed considerable experience only recently, are meeting each other at a time when medicine is in its frontiers. Just as the cancer cell biology has contributed to development of basic biologic understandings, the clinical study of cancer by an Ayurvedic physician leads to immense introspection in to the entire knowledge base built on textual basis. The experience is unique in many aspects and thus has opened a new dimension which needs to be examined in detail leading to proper understanding of the disease. In the absence of any previous experience and lack of guidance and also because of paucity of literature, it was like endeavoring a new venture. Following the advice of Charaka (1) promptly, the patients were studied with respect to their clinical parameters and detailed analysis was carried out with the help of texts. This paper presents the current concepts formulated with pragmatic approach within the frame work of Ayurveda.
OBJECTIVES AND METHODS
The main objectives is to identify the disease known by the name of "cancer" -according to Ayurveda and understand the aetiopathogenesis in the frame of DoshaDhatu-Mala triod leading to establishements of Samprathi -eventually evolving the line of treatment. Working in one of the leading cancer hospital set up in India, provided an excellent opportunity to study, hence initially all types of patients were observed at various stages by regular follow up at out patients as well as in patient. It was realized that each type of cancer needs more attention. Hence, only a few types were selected for detailed examination. With the help of a well maintained cancer registry from where the data was taken and in addition, more specific data required from Ayurvedic point of view was obtained prospectively. Review of literature, both ancient Ayurvedic texts and modern medical texts and Journals was done along with the clinical study. Discussions were held with concerned physicians on individual cases. An experimental account of six years of exercise, the conclusions were drawn utilizing the collected data.
CURRENT CONCEPTS OF CANCER
Cancer is not a single disease as generally believed. It has a very wide spectrum of conditions but have some commonness. It is now well understood that cancer is the result of cellular genetic changes leading to abnormal proliferation of such 'altered' cells which grow disproportionate to the needs of the body and pervades all vital parts if not controlled effectively. Hence its diagnosis is an elaborate but a precise process done by a biopsy of the affected tissue. Clinical examination is of course mandatory although not conclusive. The words like "neoplasm", "malignancy", "oncogenesis", "carcinogenesis", "cancer", etc are essentially attributed to such genetically determined tumour related clinical conditions. Hence cytogenetic examination is emerging as a new dependable technique. Although, clinically cancer manifests in wide spectrum of signs and symptoms, they are characterized by the involvement of definite tissue which can be identified microscopically depending on the cell of origin. The natural history and biology progresses into a definite clinical pattern. The tumour cells are monoclonal (arising from single cell) which secret certain substances, which are used as tumour markers by biochemical methods. Tumor cells migrate through lymphatic or haematological channels to other areas of the body and develop into tumours. They can even spread directly to neighbouring tissues with their immense speed of growth at the cost of the host and endagers its existence. Number of aetiological factors have been identified such as radiation, chemicals, drugs, viruses etc. The host factors itself contributes in the pathology. However, enormous amount of work is still in progress in different countries of the world. This has assumed a separate branch of medical science known as Oncology.
CANCER AND AYURVEDA
Nature's phenomenon has been the same, but man understands it in his own way at different points of time. In the history of medicine we have seen this clearly. Cancer can be stated to be the child of scientific medicine's technological innovation. The microscope that revolutionized the medicine with bacterioviral causation, also did similarly in the cellular basis concept of cancer aetiology. Obviously it is very recently understood phenomenon.
The objective evaluation of any theory is the Darshanic concept of Pratyaksha. Ayurveda and contrarily, modern medicine depends on objectivity, hence to understand cancer in the language of Ayurveda is like adding a new chapter to Nidana Sthana of Charaka samhita. The need for such a work needs to be emphasized. All that we have is a few samhitas and they are the only source of information. This work attempts to analyse (Anumana) on the basis of clinical study (Pratyaksha) correlating with the shastra (Aagama or Aaptopadesha). This confirms to the code of Ayurvedic tradition. No shastra can develop unless it keeps pace with related systems. Sushruta's advise has been well taken.
Cancer patients presenting as mass in the abdomen is one of the major area as quite number of cancers have this clinical condition commonly. Over the period of six years, a study of all cancers which are known to be associated with mass in the abdomen were taken up to understand the natural history and clinical behaviour during stages of the disease. Modern oncology has systematically established on the basis of the cell involved in different cancers in most of the varieties.
The study convincingly proved that the various classifications found in oncology is fully justified as their cell of origin, tumour developing speed, clinical behaviour, signs and symptoms, type of metastisi are well understood and demonstratable. Since these are absolutely objective and non-ambiguous the diagnosis established was taken as the base for study. 
PAEDIATRIC MALIGNACIES:
Acute leukemia Lymphnode metastasis from other primary sites.
DISCUSSION AND ANALYSIS

I. (A) Abdominal tumours
An Ayurvedic physician can think of Gulma or Udara clinically and uses all his efforts to make a diagnosis. He may finally classify under doshic category, but the precise details, exact location, relation to other organs and finally the stage cannot be clinically appreciated. Now the question of this tumour being "cancer" or not is a non entity in the absence of present oncology knowledge. The doshic classification itself will be disputable as it has a strong and inevitable subjective bias.
DISCUSSION
Gulma is one most important disease found in Ayurvedic literature to describe tumoursof the abdomen. Charaka infact has dealt only six disease of physical origin in Nidana sthana in which gulma represents the abdominal disorders with mass but Sushruta has taken under Udara. Experiences in this study clearly showed that both these are to be taken to understand abdominal malignant tumours in Ayurvedic context.
Although gulma is the most probable diagnosis clinically, all mass abdomen cases cannot be included as evident from the Table 1 . Another condition Abyantara Vidradhi was also taken up for recognizing the malignant condition, as it appeared close to gulma. Granthi is the proper term to describe tumour. Arbuda is also a granthi, but both these have not been described as abdominal tumours at all. But, both Charaka and Sushruta have mentioned gulma as a granthi originating in the gastro intestinal tract. It is a hard mass confined to the five anatomical positions. However, all the gulmas do not appear to be malignant type. The Tridoshaja or Nichaya gulma having stone hard elevated mass which is described as incurable must be a malignant tumour. The locations of gulma covers almost the entire abdomen region from diaphragam to inguinal region and hence any of the tumour in the table 1 can be gulma. But as per Sushruta gulmas doesn't involve dhatus but only doshas and hence obviously the mass doesn't originate from a tissue. From this description and also due to exclusion of gulma from surgical management it is not possible to draw conclusion about gulma's malignant identity.
Among the udara rogas yakritodara and pleehodara are to be excluded here as they have been identified without ambiguity (dealt separately in the end). Gulma like mass are said to occur in udaras and have progressively frieghtining course. Since all udaras are generally regarded as maharogas indicating extreme difficult clinical situation, and udaras are terminal events of chronic pathological process, it is felt necessary to regard some of them as malignant. Most of the explanations in the texts appear clearly on the basis of external examination and definitely not by exploratory laparotomy.
The Sannipatodara which is specially mentioned by Sushruta as Dooshyodara needs to be given special attention. It is unique in many ways. The etiology relating to dooshivisha and garavisha and producing typical serious signs and symptoms makes it appear malignant. The modern aetiology of all cancers referring to radiation, chemicals, drugs, viruses are all vishas in the Ayurvedic terminology. All the primary cancers of the abdomen and metastic cancers with primary else where ultimately produce udara and most of them also progresses to jalodara also. When we examine the environment in which we are living and food and other substances to which we are exposed to, we can imagine the extent of our exposure to so many toxic substances. Since most of them are scientifically known as toxic, these chemicals and drugs have to be taken as dooshi or gana vishas. Hence in this study dooshyodara emerged as the important disease to identify and correlate with the malignant abdominal tumours. Further, the viruddahara and vishamahara are well known to produce gara like situation which appeared very relevant from the observations made in the study. The term mahodara yakritpleehee in gara is note worthy.
The non-hodgkins lymphoma in both children and adults, advanced abdominal hodgkins disease, ovarian cancer, peritoneal and omentum metastasis of various other tumours typically, progresses and presents like dooshyodara.
125 paediatric and 180 cases of adult NIIL were studied out of which 137 cases were abdominal and other cases were either mediastinal are peripheral nodal and extra nodal. Non abdominal NHL also progresses finally reach abdomen. Hence all cases were studied. Table 2 shows the important signs and symptoms.
As explained by Sushrutai and Charaka the visha or toxic aetiology is now scientifically well established. All visha dravyas have great potential to bypass the doshas in the body and spread along all routes and vitiate the blood. The chief damage is done by destroying the ojusi due to complete opposite property. Lastly all the doshas also gets involved along with Dhatus, particularly the rakta, the whole body systems get disturbed. In the acute or chronic sequence of events initiated by innumerable unknown Visha dravyas, I propse that the visha etiology should be accepted for formation of granthi. The dooshyodora which has been proposed as NHL and other abdominal metastasic disorders based on the present study has been very well supported by number of studies. The word Granthi or tumour has been explained in both the gulmai and udara contexts by all Acharyas.
NIIL is essentially the malignant tumour of the lymphoid system. Although it presents with diverse range of diseases and sites, they have general similarities within the group as a whole. The disease originates in the primary site of lymph nodes i.e. cervical, axillary, mediastinal, abdominal and inguinal or in the extra nodal organs but very soon they spread and involve other lymphatic areas and spread to other organs. My observations clearly suggests that all abdominal tumours have to be recognized either in gulma, udara or vidradhi. There is no other diseases entity in the Ayurvedic literature relating to abdominal tumours. There is considerable amount of ambiguity and confusion and overlapping in the explanations. For eg., all the tree entities are referred as granthis, but they are different. Internal vidradhi's explanations are clearly like solid tumours but gulma with only dosha involvement is a soft mobile mass.
But gulma when chronic spreads all over the abdomen and gain the shape of turtle and becomes a killer.
Udara's by nature dreadful, non responsive and have granthi like masses. All these can be associated with vishas, as mentioned by Sushuruta.
The oncology experience and observation combining with Ayurvedic experience and literature has led me to draw conclusions in the following way.
All cancers in general and abdominal cancers studies here in particular have definite visha aetiology of dooshivisha type. The dosha lakshanas are not at all seen in most of the cancers till the disease is advanced suggests and supports this hypothesis and hence I wish to propose that vishass directly involve with the dhatus and pathogenesis is initiated. Since majority of the population do not have shudda sharers (cleansed internal environment) the situation will be favourable, and granthii will be formed. The samprapthi of granthi, arbudai and vidradhi essentially involve rakta, mamsa and medas together which I feel can be due to specific dooshivishas. The doshas automatically involved but do not show generalized symptoms as they are localized. Sushruta's six kriyakalasi certainly cannot be appreciated in solid cancers because these tumours do not undergo these dosha based stages at all. The gulma-granthi-vidradhiudara are closely associated conditions and whenever they are associated with visha aetiology perhaps the situation becomes malignant. They can also be regarded as different stages which actually differ in different tumours.
However histopathological classification, organ specific metastasis, detailed staging procedures, etc are not of much importance for the preliminary study and hence not discussed here.
More studies however should be done by team of Ayurvedic physicians for further discussions.
ABDOMINAL TUMOURS (SPECIFIC) NO. (1)
Apart from the tumours discussed above we find in the literature three specific conditions which are given separate status and relate to malignancies. These are also abdominal tumours but specific to organs referred clearly viz. Yakritodara -Pleehodra. Raktagulma is not discussed here as I have not made studies on that. These two conditions clinically referred as hepatomegaly and splenomagaly occurs in quite a number of begin and malignant conditions and they are very important clinical signs, but in Ayurvedic literature the references are not only scarce but vague and confusing (pleehodra is discussed separately). The pleeha or spleen appears to be given more importance than liver. The aetiology, pathogenesis and symptoms have been considered as common for both these organs.
According to modern oncology and from my experience liver is an important organ of metastatic spread in number of cancers and signifies advance disease but spleen metastasis is seen only in haematological malignancies which is not considered as metastasis because spleen is a part of primary haematopoetic system. In this study more than 400 cases were studied where liver involvement was documented clinically, histological and by imaging techniques. The various types of cases studied are listed below.
All patients presented with enlargement of liver and proved to be malignant were studied.
The following conditions are listed where hepatomegaly is associated. In the above mentioned conditions hepatomegaly is a definite conditions in some stage of the natural history of the disease. Histopathologically confirmed cases were followed and examined at all stages. The primary liver cancer patients have very uneventful vague history and seldom suffer from any serious problem except pain in the upper quadrant of the abdomen, but clinical exam reveals grossly enlarged liver, which is non tender and hard. Most of the patients present with huge mass with mild abdomen paid. Gradually they develop progressive loss of appetite and weight in addition aversion to food. In my observation 65% of patients developed jaundice and eventually died. However till they develop these two terminal events the quality of life was remarkably good. In case of metastic liver, the primary will be known majority of the cases. A few cases will have occult primary or a small tumour. Clinically, patients with metastic liver are more ill and even small size liver enlargement make significant difference in quality of life due to diffuse involvement and aggressive proliferation of tumour cells. Most of the cases develop jaundice and ascitis and die at a faster rate than primary carcinoma. In these cases in addition to liver the lymphnod metastasis in the abdomen will be usually associated. The haematological diseases with hepatomegaly can be clearly distinguished from other solid tumours without any ambiquity and hence they are not discussed here. Other paediatric tumours can however be taken along with solid tumours discussed above.
In Ayurvedic literature we come across a few diseases associated with hepatomegaly which is mentioned as a separate entity in some contexts. The Yakrutodara in the udara contect and kumbhaka -haleemaka in the pandukamala context and special reference as mahodara yakritpleehe in the garavisha context are considered here as they clinically correlate to many malignant conditions. The visha aetiology of Ayurveda is well supported by the modern toxic and vital aetiology. The primary liver cancer has been related to malnutrition, dietary carcinogens like nitrosamines and a toxins, parasitic infections and cirrhoea from number of causes including alcohol. The hepatitis B virus has been conclusively proved to be associated. On the basis of these evidences and Ayurvedic reference to gara and dooshivisha and udara begins well known terminal condition of chronic pathological conditions of different diseases, the yakritodara is to be considered as malignant condition, whether it is primary or metastatic (irrespective of other primaries). In the study it was very clearly seen that not only the liver metastatic cases are udara conditions but they will progress to jalodara or dooshyodara conditions.
The non malignant hepatomegaly like cirrhosis which may also progress to jalodara is to be regarded as yakrit dosha like pleehadosha or as yakritvriddi.
The concept of common aetiology and pathology for both liver and spleen mentioned in samhitas cannot be justified, since none of the evidence support. In pure lymphoid malignancies alone we can clearly appreciate the involvement of both liver and spleen but unlike other cancers they are reversible, and do not correlate with udara rogas.
The primary cancer of the liver or hepatocellular carcinoma and all carcinomas and sarcomas that metastasizes to the liver or recognizable as yakritodara mentioned in Ayurvedic literature.
ABDOMINAL TUMOURS (SPECIFIC) NO.2
The third category of mass abdomen clinical presentation that can be seen in Ayurvedic literature is "pleeha" related disorders. The terms used to describe are (1) Pleehadosha
Splenomegaly is a important sign in quite a number of both begin and malignant conditions. In this study only malignant diseases were taken. The following are the chief malignant diseases associated with splenomegaly studied. This fact is conclusively understood. Rest of the conditions are chronic in nature and splenomegaly is the chief presenting sign except the HD. The HD is in fact excluded as it has significant lymphnode involvement and splenomegaly is in fact only pleehavriddhi. The CML and HCL were the only two conditions left out since the CLL has not only low incidence but completely asymptomatic till the disease reaches terminal stage.
The CML patients were found to be unique and had typical symptoms and clinical course and attracted keen attention. 75% of the patients had gross splenomegaly which was non tender and hard and clearly like the tortoise shell (Koormapristavat) (6). CML is a clonal myclo proliferative disorder of a pluripotent stem cell of the bone marrow and all the blood elements are involved. The media age is 50 years and undoubtedly a adult disese. It can easily be diagnosed by peripheral blood examination showing abnormal increase of the total count with lot of immature cells. Usually it has a chronic phase ranging several years and then accelerate suddenly and goes to blastic or acute phase which is the terminal event of the disease process.
The pleehodara mentioned in all the three classics have very clear resemblance to the CML observed in this study. The signs and symptoms given above shows almost all the cases had similar presentation. Prognosis is definitely bad as envisaged in Ayurveda. However, by the presently available therapy, the chronic phase can be extended to a few years.
Except CML, none of the other splenomegaly groups has any resemblance to pleehodara. Since udara roga has been grouped under maharogasi and pleehodara specially recognized as 4 th in the order of Krichrata and the literature description was very obviously observed in the group studied in CML, the Pleehodara is to be taken as Chronic Myeloid Leukemia. Further there is no other disease that can be considered in the cancer group. However, the begin diseases have not been taken into consideration as they are unlikely to be udara but only pleehadosha or pleeha vridhi in my opinion.
CONCLUSION
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Systematically worked up malignant mass abdomen cases has been discussed in the Ayurvedic framework. I have proposed the Ayurvedic visha aetiology as having very strong malignant potential. Since the vishas have independent components to initiate a unique pathological process which is known to get involved with doshas and dhatus later, all cancers in general and the diseases discussed here in particular are to be taken as vishajanya granthi vikaras. I have concluded that UDARA-GULMA-VIDRADI are the abdominal tumours which are having what we today understand as "malignant" or cancerous potential. Further I wish to conclude that the modern diagnosis in the name of CANCER can never be equated with any single disease entity mentioned in Ayurvedic literature. Modern concepts itself clearly says cancer is not a single kind of disease. ARBUDA which is generally taken for all cancers is incorrect in this context as evident from the study of the abdominal tumours presented here.
